替代疗效终点定义对阵发性心房颤动消融后报告结果的影响——来自使用连续节律监测的COMPARE-CRYO研究的见解

IF 5.7 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Salik Ur Rehman Iqbal, Thomas Kueffer, Sven Knecht, Patrick Badertscher, Jens Maurhofer, Philipp Krisai, Corinne Jufer, Gregor Thalmann, Dik Heg, Helge Servatius, Hildegard Tanner, Michael Kühne, Laurent Roten, Christian Sticherling, Tobias Reichlin
{"title":"替代疗效终点定义对阵发性心房颤动消融后报告结果的影响——来自使用连续节律监测的COMPARE-CRYO研究的见解","authors":"Salik Ur Rehman Iqbal, Thomas Kueffer, Sven Knecht, Patrick Badertscher, Jens Maurhofer, Philipp Krisai, Corinne Jufer, Gregor Thalmann, Dik Heg, Helge Servatius, Hildegard Tanner, Michael Kühne, Laurent Roten, Christian Sticherling, Tobias Reichlin","doi":"10.1016/j.hrthm.2025.09.026","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recurrence after atrial fibrillation (AF) ablation is commonly defined as any atrial arrhythmia lasting >30sec. It is unclear how alternative efficacy endpoint definitions would change the observed success rates and how they would relate to patients' disease burden or healthcare utilization metrics.</p><p><strong>Objective: </strong>To evaluate the impact of alternative endpoint definitions after AF ablation based on AF-burden, duration or number of episodes using implantable cardiac monitors (ICM).</p><p><strong>Methods: </strong>This is a prespecified substudy of the COMPARE-CRYO study, which enrolled patients with paroxysmal AF undergoing cryoballoon ablation. All patients underwent ICM implantation and the blanking period was 90 days. Details were collected on timing, duration and number of episodes and AF-burden between 91-365 days. Outcome measures were redo ablations and AF-related hospitalizations.</p><p><strong>Results: </strong>The primary endpoint of any recurrence lasting >30 sec occurred in 89 of 201 patients (44%). One-year success rates increased with increasing arrhythmia duration thresholds from 56% (≥30 sec) to 97% (≥24h), with number of episode thresholds from 56% (≥1 episode) to 98% (≥100 episodes) and with AF-burden thresholds from 56% (AF-burden >0%) to 93% (AF-burden >2%). Rates of redo ablations and AF-related hospitalizations increased for AF-episode durations >1h, >6 AF-episodes and an AF-burden >0.1%, and were highest for AF-episode durations >24h, >33 AF-episodes and an AF-burden >1%.</p><p><strong>Conclusion: </strong>Alternative efficacy endpoint definitions have a significant impact on reported outcomes and healthcare utilization metrics after AF ablation. These findings are important when considering endpoint definitions other than the traditional 30 seconds in the design of future AF-ablation trials.</p>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of alternative efficacy endpoint definitions on reported outcomes after ablation of paroxysmal atrial fibrillation - insights from the COMPARE-CRYO study using continuous rhythm monitoring.\",\"authors\":\"Salik Ur Rehman Iqbal, Thomas Kueffer, Sven Knecht, Patrick Badertscher, Jens Maurhofer, Philipp Krisai, Corinne Jufer, Gregor Thalmann, Dik Heg, Helge Servatius, Hildegard Tanner, Michael Kühne, Laurent Roten, Christian Sticherling, Tobias Reichlin\",\"doi\":\"10.1016/j.hrthm.2025.09.026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Recurrence after atrial fibrillation (AF) ablation is commonly defined as any atrial arrhythmia lasting >30sec. It is unclear how alternative efficacy endpoint definitions would change the observed success rates and how they would relate to patients' disease burden or healthcare utilization metrics.</p><p><strong>Objective: </strong>To evaluate the impact of alternative endpoint definitions after AF ablation based on AF-burden, duration or number of episodes using implantable cardiac monitors (ICM).</p><p><strong>Methods: </strong>This is a prespecified substudy of the COMPARE-CRYO study, which enrolled patients with paroxysmal AF undergoing cryoballoon ablation. All patients underwent ICM implantation and the blanking period was 90 days. Details were collected on timing, duration and number of episodes and AF-burden between 91-365 days. Outcome measures were redo ablations and AF-related hospitalizations.</p><p><strong>Results: </strong>The primary endpoint of any recurrence lasting >30 sec occurred in 89 of 201 patients (44%). One-year success rates increased with increasing arrhythmia duration thresholds from 56% (≥30 sec) to 97% (≥24h), with number of episode thresholds from 56% (≥1 episode) to 98% (≥100 episodes) and with AF-burden thresholds from 56% (AF-burden >0%) to 93% (AF-burden >2%). Rates of redo ablations and AF-related hospitalizations increased for AF-episode durations >1h, >6 AF-episodes and an AF-burden >0.1%, and were highest for AF-episode durations >24h, >33 AF-episodes and an AF-burden >1%.</p><p><strong>Conclusion: </strong>Alternative efficacy endpoint definitions have a significant impact on reported outcomes and healthcare utilization metrics after AF ablation. These findings are important when considering endpoint definitions other than the traditional 30 seconds in the design of future AF-ablation trials.</p>\",\"PeriodicalId\":12886,\"journal\":{\"name\":\"Heart rhythm\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2025-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heart rhythm\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.hrthm.2025.09.026\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.hrthm.2025.09.026","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:房颤(AF)消融后复发通常被定义为任何持续30秒的房性心律失常。目前尚不清楚替代疗效终点定义将如何改变观察到的成功率,以及它们与患者疾病负担或医疗保健利用指标之间的关系。目的:利用植入式心脏监护仪(ICM)评估基于心房颤动负荷、持续时间或发作次数的房颤消融后替代终点定义的影响。方法:这是COMPARE-CRYO研究的一个预先指定的亚研究,该研究招募了接受冷冻球囊消融的阵发性房颤患者。所有患者均行ICM植入,空白期为90 d。收集了91-365天的发病时间、持续时间和次数以及af负担的详细信息。结果测量为再次消融和房颤相关住院。结果:201例患者中有89例(44%)的主要终点出现了任何持续bb30秒的复发。随着心律失常持续时间阈值从56%(≥30秒)增加到97%(≥24小时),发作次数阈值从56%(≥1次)增加到98%(≥100次),af -负担阈值从56% (af -负担>0%)增加到93% (af -负担>2%),一年的成功率也随之增加。急性房颤发作持续时间为bb10小时,bb10小时6次,急性房颤负荷bb12 %时,房颤消融率和房颤相关住院率增加,房颤发作持续时间为bb10小时,bb11小时33次,房颤负荷bb5 %时,房颤消融率最高。结论:其他疗效终点定义对房颤消融后报告的结果和医疗保健利用指标有显著影响。在设计未来af消融试验时,考虑到除传统的30秒之外的终点定义,这些发现很重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of alternative efficacy endpoint definitions on reported outcomes after ablation of paroxysmal atrial fibrillation - insights from the COMPARE-CRYO study using continuous rhythm monitoring.

Background: Recurrence after atrial fibrillation (AF) ablation is commonly defined as any atrial arrhythmia lasting >30sec. It is unclear how alternative efficacy endpoint definitions would change the observed success rates and how they would relate to patients' disease burden or healthcare utilization metrics.

Objective: To evaluate the impact of alternative endpoint definitions after AF ablation based on AF-burden, duration or number of episodes using implantable cardiac monitors (ICM).

Methods: This is a prespecified substudy of the COMPARE-CRYO study, which enrolled patients with paroxysmal AF undergoing cryoballoon ablation. All patients underwent ICM implantation and the blanking period was 90 days. Details were collected on timing, duration and number of episodes and AF-burden between 91-365 days. Outcome measures were redo ablations and AF-related hospitalizations.

Results: The primary endpoint of any recurrence lasting >30 sec occurred in 89 of 201 patients (44%). One-year success rates increased with increasing arrhythmia duration thresholds from 56% (≥30 sec) to 97% (≥24h), with number of episode thresholds from 56% (≥1 episode) to 98% (≥100 episodes) and with AF-burden thresholds from 56% (AF-burden >0%) to 93% (AF-burden >2%). Rates of redo ablations and AF-related hospitalizations increased for AF-episode durations >1h, >6 AF-episodes and an AF-burden >0.1%, and were highest for AF-episode durations >24h, >33 AF-episodes and an AF-burden >1%.

Conclusion: Alternative efficacy endpoint definitions have a significant impact on reported outcomes and healthcare utilization metrics after AF ablation. These findings are important when considering endpoint definitions other than the traditional 30 seconds in the design of future AF-ablation trials.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Heart rhythm
Heart rhythm 医学-心血管系统
CiteScore
10.50
自引率
5.50%
发文量
1465
审稿时长
24 days
期刊介绍: HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability. HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信